2257 — Sirnaomics Income Statement
0.000.00%
Last trade - 00:00- HK$315.50m
- HK$175.60m
- $1.78m
Annual income statement for Sirnaomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 1.78 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 1.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 46.2 | 216 | 96.6 | 84 | 51 |
| Operating Profit | -46.2 | -216 | -96.6 | -84 | -49.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -46.4 | -216 | -97.4 | -85 | -50.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -46.4 | -216 | -97.4 | -85 | -50.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -43.8 | -213 | -88.3 | -78.7 | -51.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -43.8 | -213 | -88.3 | -78.7 | -51.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.397 | -13.5 | -1.16 | -0.95 | -0.635 |